General OA media and info, page-645

They outsource everything (well almost).
Remember, the Chairman & CEO outsourced the courting process for pharma partnership, leaving him to do what exactly? As you the correctly point out, the register is particularly void of any healthcare specialist funds.... Actually, did any new funds participate in the most recent cap raise?
They outsource the data collation & preparation for regulatory submission.
Obviously outsource the trials themselves.
They outsource research (Edison).
So internally they have a BOD (Amos, PR, Donna, new guy & whoelse?) an IR guy, a company secretary / CFO, & Beverley, who is screening new potential mid size pharmas, that they have also asked a shareholder to help out with on a consulting basis for 7.5m options (out of the money of course).

Yes, I am trying to be sarcastic, but you can see they have a few people, just no-one with the requisite skills to do much, outside of Donna.

So they have shelved MPS, cut quite a few consultants, but added 1 for 7.5m options and a modest salary.

Who are we missing fanboys??